Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Tofacitinib might be used to treat hair loss.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Bortezomib chemotherapy can cause temporary skin rashes.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

LGD1069 effectively prevents breast tumors in mice without toxicity.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.